Skip to main content

Table 1 Demographics and delivery characteristics of women enrolled in the study

From: A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt

 

N

Primary Prevention

Secondary Prevention

N clusters

20

10

10

N of women enrolled

2654

1555

1099

N women per cluster, average (range)

20

156 (48–317)

110 (35–188)

Demographics and Obstetric Historya

 Age, mean (SD)

2653

25.4 (5.0)

25.8 (5.1)

 Educationb

  No/informal education

726

408 (26.3%)

318 (29.1%)

  Primary/Preparatory

795

505 (32.6%)

290 (26.5%)

  Secondary and above

1124

638 (41.1%)

486 (44.4%)

 Nulliparous

562

348 (22.4%)

214 (19.5%)

 Gravida, mean (SD)

2654

2.4 (1.1)

2.5 (1.1)

 Known PPH in past pregnanciesc

48

25 (1.6%)

23 (2.1%)

Delivery Characteristicsa

 Place of birth

  Home of woman or midwife

2636

1539 (99.0%)

1097 (99.8%)

  PHU

18

16 (1.0%)

2 (0.2%)

 Pre-delivery Hb,

  Mean (SD)

2654

11.3 (1.2)

11.3 (1.1)

  Pre-delivery Hb < 11.0

1015

595 (38.3%)

420 (38.2%)

 Gestational age when Hb measured in weeks, mean (SD)

2654

38.7 (1.3)

38.9 (1.3)

 Uterotonic given before delivery

52

10 (0.6%)

42 (3.8%)

 Procedure during 3rd stage of labor

  Uterine massage

1139

709 (45.6%)

430 (39.1%)

  Controlled cord traction

357

222 (14.3%)

135 (12.3%)

 Non-study uterotonic given during 3rd stage of labor

2654

2 (0.1%)

11 (1.0%)

 Blood absorption mat used after delivery

2649

1550 (99.7%)

1099 (100%)

  1. aResults are presented as N (%) except where otherwise noted
  2. b4 women in PP group and 5 women in SP group had unknown education level
  3. c37 women in PP group and 4 women in SP group had unknown information for previous PPH